Weichang Zhou, Ph.D.

Senior Vice President, Biologics Development and Manufacturing & Chief Technology Officer
WuXi Biologics

Dr. Weichang Zhou received his Ph.D. in Chemical Engineering and Biotechnology from University of Hannover, Germany in 1989. He conducted biochemical engineering postdoctoral research at German DECHEMA (German Society for Chemical Equipment, Chemical Technology & Biotechnology) - Institute, Swiss Federal Institute of Technology (ETH-Zurich) and University of Minnesota, USA. Dr. Zhou is a strong, well-recognized technical and managerial leader with 20+ years of broad industrial experience and demonstrated accomplishments in biologics (recombinant proteins, monoclonal antibodies and viral vaccines) manufacturing process development, scale-up, characterization, technology transfer, manufacturing and regulatory support. He has been providing scientific excellence and strategic leaderships to many multifunctional CMC teams by serving as senior executive leadership positions at WuXi AppTec, Senior Director of Commercial Cell Culture Development at Genzyme, a SANOFI Company, Senior Director of Process Sciences and Engineering at PDL BioPharma and Associate Director of Fermentation and Cell Culture at Merck. Currently he is serving as Senior Vice President, Biologics Development and Manufacturing, leading all biologics development and CMC activities as well as manufacturing and release of early stage clinical supplies. He is leading a biologics development team of more than 600 scientists and engineers providing integrated biologics services in Shanghai and Wuxi, China, the largest biologics development team in the contract development and manufacturing organizations worldwide.

Dr. Zhou has published over 50 scientific papers and hold four patents. He has delivered over 100 presentations and lectures in international conferences and professional courses. He has been organizing and chairing conferences and symposia on topics related to development and commercialization of bioprocesses and biologics. He served as one of two chairs for the Cell Culture Engineering (XIV) 2014 conference, Biochemical Engineering (XIII) 2003 conference and 2004 program of the Division of Biochemical Technology, American Chemical Society in the 227th ACS Spring National Meeting. He was elected as a fellow of the American Chemical Society in 2013 and a fellow of the American Institute for Medical and Biological Engineering (AIMBE) in 2002. Dr. Zhou was an executive committee member of the Division of Biochemical Technology (BIOT), American Chemical Society between 2003 and 2014 having served as division’s Program Chair (2004), Awards Chair (2005-2008), Division's Chair-Elect (2008), Chair (2009) and Past-Chair (2010).

Weichang Zhou